PRKAA1 and osteosarcoma: Dr. Morishita and colleagues explored the therapeutic potential of promoting mitochondrial proliferation in human osteosarcoma (OS) cells through the activation of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α) by AMPK.